Mexico - Delayed Quote MXN

Novartis AG (NVSN.MX)

2,235.00

0.00

(0.00%)

As of March 20 at 12:10:52 PM CST. Market Open.

Revenue vs. Earnings

Revenue 13.15B

Earnings 3.93B

Q1'24

Q2'24

Q3'24

Q4'24

0

5B

10B

Analyst Price Targets

No Analyst Price Targets available for this ticker

Currency in USD	Current Qtr. (Mar 2025)	Next Qtr. (Jun 2025)	Current Year (2025)	Next Year (2026)
No. of Analysts	--	--	--	--
Avg. Estimate	0	0	0	0
Low Estimate	0	0	0	0
High Estimate	0	0	0	0
Year Ago EPS	--	--	--	--

Currency in USD	Current Qtr. (Mar 2025)	Next Qtr. (Jun 2025)	Current Year (2025)	Next Year (2026)
No. of Analysts	5	4	16	17
Avg. Estimate	13.04B	13.81B	53.45B	54.44B
Low Estimate	12.86B	13.55B	52.11B	50B
High Estimate	13.17B	14.24B	55.86B	58.33B
Year Ago Sales	11.83B	12.51B	50.32B	53.45B
Sales Growth (year/est)	10.24%	10.39%	6.22%	1.87%

Currency in USD	Current Qtr. (Mar 2025)	Next Qtr. (Jun 2025)	Current Year (2025)	Next Year (2026)
Current Estimate	0	0	0	0
7 Days Ago	0	0	0	0
30 Days Ago	0	0	0	0
60 Days Ago	0	0	0	0
90 Days Ago	0	0	0	0

Currency in USD	Current Qtr. (Mar 2025)	Next Qtr. (Jun 2025)	Current Year (2025)	Next Year (2026)
Up Last 7 Days	--	--	--	--
Up Last 30 Days	--	--	--	--
Down Last 7 Days	--	--	--	--
Down Last 30 Days	--	--	--	--

	Current Qtr.	Next Qtr.	Current Year	Next Year
NVSN.MX	--	--	--	--
S&P 500	6.94%	4.52%	8.32%	14.18%

Downgrade	UBS: Buy to Neutral	2/13/2025
Downgrade	Erste Group: Buy to Hold	11/19/2024
Maintains	BMO Capital: Market Perform to Market Perform	10/30/2024
Downgrade	B of A Securities: Buy to Neutral	9/11/2024
Downgrade	Goldman Sachs: Buy to Neutral	9/5/2024
Downgrade	Jefferies: Buy to Hold	9/3/2024